Equities
Health CareHealth Care Equipment & Services
  • Price (USD)1,037.27
  • Today's Change3.26 / 0.32%
  • Shares traded635.36k
  • 1 Year change+52.34%
  • Beta1.0617
Data delayed at least 15 minutes, as of Sep 17 2021 21:00 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Intuitive Surgical, Inc. develops, manufactures and markets the da Vinci surgical system and Ion endoluminal system. The Company's da Vinci products are offered in categories, including da Vinci Surgical Systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems (Firefly) and da Vinci Endoscopes. It also provides a comprehensive suite of services, training, and education programs. It manufactures a set of instruments, which incorporates EndoWrist technology with wristed joints for natural dexterity and tips customized for various surgical procedures. Its Ion endoluminal system is a robotic-assisted, catheter-based platform designed to navigate through very small lung airways to reach peripheral nodules for biopsies. The da Vinci Surgical System enables surgeons to operate while seated at an ergonomic console viewing a three-dimensional, high definition (3DHD) image of the surgical field.

  • Revenue in USD (TTM)5.16bn
  • Net income in USD1.62bn
  • Incorporated1995
  • Employees8.08k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Boston Scientific Corporation11.20bn526.00m63.18bn38.00k120.653.9638.815.640.36780.36787.8311.210.36132.557.15294,657.901.883.032.133.7866.4569.705.217.171.31--0.36360.00-7.665.80-119.23--0.3484--
Edwards Lifesciences Corp4.93bn1.46bn74.44bn14.90k51.6814.5046.8515.112.312.317.788.240.69931.618.15330,550.3020.7614.6923.7317.4875.5374.5129.6921.522.89--0.10390.000.880911.96-21.5610.7230.77--
Becton Dickinson and Co19.90bn1.87bn75.23bn72.00k41.143.1218.363.786.376.3767.8884.040.36753.569.77276,333.303.612.434.142.7747.2746.949.836.780.85067.400.423680.41-1.0010.73-25.681.995.055.66
Stryker Corporation16.25bn2.08bn102.96bn43.00k49.987.4534.086.345.465.4642.6036.650.49851.716.61377,814.006.397.327.378.7263.8765.6912.8213.781.32--0.479739.73-3.587.61-23.242.1312.5216.25
Intuitive Surgical, Inc.5.16bn1.62bn123.43bn8.08k77.5011.3663.1723.9113.3813.3842.6191.300.4612.668.54638,893.7014.6313.9916.0615.5968.6968.8431.7428.805.42--0.000.00-2.6812.82-23.1112.4933.35--
Medtronic PLC31.60bn3.88bn174.55bn90.00k45.233.3926.405.522.872.8723.3638.290.34032.366.13351,077.804.214.774.755.3666.9568.5112.3714.962.3415.470.334560.934.160.8752-25.94-0.21575.318.83
Data as of Sep 17 2021. Currency figures normalised to Intuitive Surgical Inc's reporting currency: US Dollar USD

Institutional shareholders

37.22%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 20218.97m7.54%
The Vanguard Group, Inc.as of 30 Jun 20218.70m7.31%
BlackRock Fund Advisorsas of 30 Jun 20215.24m4.40%
SSgA Funds Management, Inc.as of 30 Jun 20214.74m3.99%
Fidelity Management & Research Co. LLCas of 30 Jun 20214.03m3.39%
Capital Research & Management Co. (World Investors)as of 30 Jun 20213.62m3.04%
Edgewood Management LLCas of 30 Jun 20212.84m2.39%
Morgan Stanley Investment Management, Inc.as of 30 Jun 20212.24m1.88%
Geode Capital Management LLCas of 30 Jun 20212.00m1.68%
AllianceBernstein LPas of 30 Jun 20211.90m1.59%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image